56 related articles for article (PubMed ID: 3580508)
1. An original method for submacroscopic metastases visualization in cases of cancer minimal residual disease.
Le Pape A; Barot-Ciorbaru R; Musset M; Baulieu JL; Jubault C; Lemarié E; Pourcelot L; Besnard JC; Nicolau C; Mathé G
Biomed Pharmacother; 1986; 40(10):392-8. PubMed ID: 3580508
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
Diel IJ; Cote RJ
Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
[TBL] [Abstract][Full Text] [Related]
3. Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma.
Battayani Z; Grob JJ; Xerri L; Noe C; Zarour H; Houvaeneghel G; Delpero JR; Birmbaum D; Hassoun J; Bonerandi JJ
Arch Dermatol; 1995 Apr; 131(4):443-7. PubMed ID: 7726587
[TBL] [Abstract][Full Text] [Related]
4. Sentinel node identification by scintigraphic methods in cutaneous melanoma.
Dias Moreira R; Altino de Almeida S; Maliska Guimarães CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM
J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749
[TBL] [Abstract][Full Text] [Related]
5. Detection of occult melanoma cells in sentinel lymph nodes and blood.
Reintgen DS; Conrad AJ
Semin Oncol; 1997 Feb; 24(1 Suppl 4):S11-5. PubMed ID: 9122728
[TBL] [Abstract][Full Text] [Related]
6. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
[TBL] [Abstract][Full Text] [Related]
7. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
Keijzer R; Bril H; van der Loo EM; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significant of sialic acid concentrations in the serum of melanoma patients].
Hermann WP; Gielen W
Hautarzt; 1980 Apr; 31(4):184-7. PubMed ID: 7399910
[TBL] [Abstract][Full Text] [Related]
9. [Tumor markers in melanoma].
Morsches B; Prellwitz W; Benes P; Schramm P; Trumpfheller R; Korting GW
Dermatol Monatsschr; 1984; 170(6):380-90. PubMed ID: 6205909
[No Abstract] [Full Text] [Related]
10. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
[TBL] [Abstract][Full Text] [Related]
11. Management of melanoma metastasis to the breast: case series and review of the literature.
Loffeld A; Marsden JR
Br J Dermatol; 2005 Jun; 152(6):1206-10. PubMed ID: 15948983
[TBL] [Abstract][Full Text] [Related]
12. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
13. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma.
Page AJ; Carlson GW; Delman KA; Murray D; Hestley A; Cohen C
Am Surg; 2007 Jul; 73(7):674-8; discussion 678-9. PubMed ID: 17674939
[TBL] [Abstract][Full Text] [Related]
14. Immunocytological detection of isolated tumour cells in the bone marrow of malignant melanoma patients: a new method for the detection of minimal residual disease.
Thybusch-Bernhardt A; Klomp HJ; Maas T; Kremer B; Juhl H
Eur J Surg Oncol; 1999 Oct; 25(5):498-502. PubMed ID: 10527598
[TBL] [Abstract][Full Text] [Related]
15. Molecular staging for melanoma and breast cancer.
Shivers SC; Stall A; Goscin C; Trudeau W; Li W; Haddad FF; Reintgen DS
Surg Oncol Clin N Am; 1999 Jul; 8(3):515-26. PubMed ID: 10448694
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
17. [Regional lymph nodes at a distance].
Kroon BB; Hoefnagel CA; Valdés Olmos RA; Nieweg OE
Ned Tijdschr Geneeskd; 2008 Sep; 152(37):1997-2000. PubMed ID: 18825884
[TBL] [Abstract][Full Text] [Related]
18. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.
Barnholtz-Sloan JS; Sloan AE; Davis FG; Vigneau FD; Lai P; Sawaya RE
J Clin Oncol; 2004 Jul; 22(14):2865-72. PubMed ID: 15254054
[TBL] [Abstract][Full Text] [Related]
19. [The detection of melanoma metastases in sentinel nodes by polymerase chain reaction].
Poelman M; van der Velde-Zimmermann D; van Doorn LJ; Quint WG; van Krimpen C; de Graaf PW
Ned Tijdschr Geneeskd; 1998 Apr; 142(16):905-8. PubMed ID: 9623187
[TBL] [Abstract][Full Text] [Related]
20. Detection of tyrosinase mRNA from the blood of melanoma patients.
Stevens GL; Scheer WD; Levine EA
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):293-6. PubMed ID: 8722221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]